MedPath

Qilu Antibiotics Pharmaceutical Co., Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NPRA:2

Drug Approvals

Meropenem-AFT 500mg Powder for Solution for Injection or Infusion

Approval Date
Jul 4, 2025
Company
aft pharmaceuticals (se asia) sdn bhd
NPRA

Meropenem-AFT 1000mg Powder for Solution for Injection or Infusion

Approval Date
Jul 4, 2025
Company
aft pharmaceuticals (se asia) sdn bhd
NPRA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.